Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study

Conclusion. Addition of Ribraxx to curcumin therapy may be of benefit to patients with early-stage B-cell lymphoid malignancies.

Source: Integrative Cancer Therapies - May 12, 2016 Category: Cancer & Oncology Authors: Golombick, T., Diamond, T. H., Manoharan, A., Ramakrishna, R. Tags: Articles Source Type: research